Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032599 | SCV001195906 | pathogenic | Cohen syndrome | 2019-09-17 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-17 of the VPS13B gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 17 of the VPS13B gene. This is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with VPS13B-related conditions. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). For these reasons, this variant has been classified as Pathogenic. |